- Home
- VLGEA vs RLAY Comparison
VLGEA vs RLAY Comparison
Compare VLGEA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLGEA
- RLAY
- Stock Information
- Founded
- VLGEA 1937
- RLAY 2015
- Country
- VLGEA United States
- RLAY United States
- Employees
- VLGEA N/A
- RLAY N/A
- Industry
- VLGEA Food Chains
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VLGEA Consumer Staples
- RLAY Health Care
- Exchange
- VLGEA Nasdaq
- RLAY Nasdaq
- Market Cap
- VLGEA 541.1M
- RLAY 619.0M
- IPO Year
- VLGEA N/A
- RLAY 2020
- Fundamental
- Price
- VLGEA $39.27
- RLAY $4.13
- Analyst Decision
- VLGEA
- RLAY Strong Buy
- Analyst Count
- VLGEA 0
- RLAY 13
- Target Price
- VLGEA N/A
- RLAY $18.00
- AVG Volume (30 Days)
- VLGEA 37.7K
- RLAY 1.2M
- Earning Date
- VLGEA 10-07-2025
- RLAY 11-05-2025
- Dividend Yield
- VLGEA 2.53%
- RLAY N/A
- EPS Growth
- VLGEA 12.55
- RLAY N/A
- EPS
- VLGEA 3.80
- RLAY N/A
- Revenue
- VLGEA $2,299,253,000.00
- RLAY $8,355,000.00
- Revenue This Year
- VLGEA N/A
- RLAY $31.55
- Revenue Next Year
- VLGEA N/A
- RLAY N/A
- P/E Ratio
- VLGEA $10.46
- RLAY N/A
- Revenue Growth
- VLGEA 3.94
- RLAY N/A
- 52 Week Low
- VLGEA $28.33
- RLAY $1.78
- 52 Week High
- VLGEA $40.15
- RLAY $8.32
- Technical
- Relative Strength Index (RSI)
- VLGEA 69.03
- RLAY 62.89
- Support Level
- VLGEA $36.85
- RLAY $3.89
- Resistance Level
- VLGEA $37.69
- RLAY $4.20
- Average True Range (ATR)
- VLGEA 0.80
- RLAY 0.23
- MACD
- VLGEA 0.31
- RLAY 0.02
- Stochastic Oscillator
- VLGEA 84.19
- RLAY 76.05
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).